Home Stock

Stock Research: Dexcom

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Dexcom

NSQ:DXCM US2521311074
37
  • Value
    22
  • Growth
    43
  • Safety
    Safety
    57
  • Combined
    28
  • Sentiment
    59
  • 360° View
    360° View
    37
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

DexCom, Inc. is a medical device company focused on continuous glucose monitoring systems. The company operates in the medical device industry and its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The company enables people to take control of health through innovative biosensing technology. In the last fiscal year, the company had a market cap of $33,519 million, profits of $2,492 million, revenue of $4,033 million, and 10300 employees.

more

ANALYSIS: With an Obermatt 360° View of 37 (better than 37% compared with alternatives), overall professional sentiment and financial characteristics for the stock Dexcom are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Dexcom. The consolidated Sentiment Rank has a good rank of 59, which means that professional investors are more optimistic about the stock than for 59% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 57 or better than 57% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 22, meaning that the share price of Dexcom is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 43. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Liquidity
Country USA
Industry Health Care Equipment
Size X-Large
Website dexcom.com
Index
NASDAQ 100
NASDAQ
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Dexcom stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 7-May-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
22 9 4 5
Growth
43 65 87 45
Safety
Safety
57 39 29 29
Sentiment
59 82 89 100
360° View
360° View
37 42 67 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
51 95 95 79
Opinions Change
50 52 63 67
Pro Holdings
n/a 88 98 94
Market Pulse
23 37 47 67
Sentiment
59 82 89 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
22 9 4 5
Growth
43 65 87 45
Safety Safety
57 39 29 29
Combined
28 19 27 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
32 17 5 6
Price vs. Earnings (P/E)
26 14 10 20
Price vs. Book (P/B)
36 20 12 14
Dividend Yield
1 1 1 1
Value
22 9 4 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
55 73 75 67
Profit Growth
86 76 94 34
Capital Growth
21 51 34 9
Stock Returns
28 27 67 91
Growth
43 65 87 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
58 20 22 25
Refinancing
15 14 17 25
Liquidity
92 97 90 67
Safety Safety
57 39 29 29

Similar Stocks

Discover high‑ranked alternatives to Dexcom and broaden your portfolio horizons.

Keurig Dr Pepper

NSQ:KDP
Country: USA
Industry: Soft Drinks
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews